PSA vs TERN · rev $4.82B vs $6.12B cap
PSA (PSA) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PSA currently screens at market cap $0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PSA and TERN stock pages for the full models.
Not investment advice.